相关实验视频
Updated: Sep 17, 2025

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
112.3K
小分子诱导的液-液相分离抑制了β-catenin的致癌性
Jin Yan1,2,3, Heyuan Liu2,3, Wenguang Yang1
1Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P. R. China.
Nature communications
|July 2, 2025
概括
研究人员开发了一种新的策略,通过诱导它们的相分离成为生物分子凝聚物来向致病蛋白. 一个小分子,RQ,有效地在肝癌细胞中隔离致癌β-catenin,从而导致瘤抑制.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 生物分子凝聚物是没有膜的细胞区,可以隔离蛋白质.
- 针对缺乏酶活性的疾病驱动蛋白质是传统药物开发的挑战.
- 目前的凝聚物调节策略无法达到许多这样的蛋白质.
研究的目的:
- 开发一种替代策略来向以前无法向的蛋白质.
- 在目标蛋白质中通过不稳定诱导液体-液体相分离 (LLPS).
- 为由β-catenin驱动的肝癌创造一种新的治疗方法.
主要方法:
- 开发了一个小分子RQ来破坏目标蛋白质的稳定并诱导LLPS.
- 利用纳米粒子形式的RQ (与蛋白结合的阿布罗) 进行有针对性的输送.
- 研究了RQ对beta-catenin在肝癌细胞中的局部化和活性的影响.
- 在临床前模型中评估了瘤生长抑制和免疫逃避.
主要成果:
- RQ成功诱导了β-catenin的细胞质凝聚物,防止核进入.
- 结合白的阿布罗金选择性地向并杀死β-catenin驱动的肝癌细胞.
- 这种方法证明了抑制瘤生长和克服免疫逃避.
- 这种方法为向以前被认为是无毒的蛋白质提供了一个新的范式.
结论:
- 诱导蛋白质相分离是一种可行的策略,用于向不耐药蛋白质.
- 对于β-catenin驱动的肝癌,RQ代表了一个有前途的治疗剂.
- 这种方法有可能在癌症治疗中克服耐药性和免疫逃避.
相关概念视频
Catenins
2.4K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.4K
Separation of Sister Chromatids
3.8K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.8K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K

